San Francisco, CA and Mullica Hill, NJ (PRWEB) May 08, 2013
Provonix, a customer-focused CRO providing innovative clinical trial solutions for pharmaceutical, biotechnology, and medical device companies, today joined the Medrio Partner Program after earning accreditation in Medrio’s eClinical Software as a Software (SaaS) platform. The Medrio Partner Program is a collaborative effort aligning Medrio resources with trusted contract research organizations (CROs) and consultancies to deliver superior customer experiences in clinical research.
“Provonix is very excited to be part of Medrio’s Partner Program,” said Jeff Botbyl, Founder and CEO of Provonix. “Combining our expertise in clinical research with Medrio’s innovative eClinical software solution will bring great value to our clients. Delivering exceptional services is a win for both companies.”
Medrio’s Partner Program offers financial incentives, comprehensive partner training, extensive sales and marketing support, and deep product insight to all partners.
“Medrio is pleased to welcome Provonix to our Partner Program. We look forward to working closely with Provonix to continue to scale our documented excellence in customer experience,” says Scott Weidley, Director of Sales & Marketing for Medrio.
About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract r
Copyright©2012 Vocus, Inc.
All rights reserved